← Evidence map

ArticleOncotarget2017

CDK4/6 inhibition is more active against the glioblastoma proneural subtype.

Ming Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

41 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 28903422